Cargando…
DNA vaccination against oncoantigens: A promise
The emerging evidence that DNA vaccines elicit a protective immune response in rodents, dogs and cancer patients, coupled with the US Food and Drug Administration (FDA) approval of an initial DNA vaccine to treat canine tumors is beginning to close the gap between the optimistic experimental data an...
Autores principales: | Iezzi, Manuela, Quaglino, Elena, Amici, Augusto, Lollini, Pier-Luigi, Forni, Guido, Cavallo, Federica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382874/ https://www.ncbi.nlm.nih.gov/pubmed/22737607 http://dx.doi.org/10.4161/onci.19127 |
Ejemplares similares
-
The Promise of Preventive Cancer Vaccines
por: Lollini, Pier-Luigi, et al.
Publicado: (2015) -
CSPG4: a prototype oncoantigen for translational immunotherapy studies
por: Rolih, Valeria, et al.
Publicado: (2017) -
Microenvironment, Oncoantigens, and Antitumor Vaccination: Lessons Learned from BALB-neuT Mice
por: Conti, Laura, et al.
Publicado: (2014) -
Multi-level model for the investigation of oncoantigen-driven vaccination effect
por: Cordero, Francesca, et al.
Publicado: (2013) -
Chimeric DNA Vaccines against ErbB2(+) Carcinomas: From Mice to Humans
por: Quaglino, Elena, et al.
Publicado: (2011)